Back to results
US 2003/0224470 A1Published application
Method of diagnosing statin myopathy
OwnerPaul S Phillipsinventor
Life of this patent
Estimating the term…
Abstract
The use of statins for the control of hypercholesterolemia is continually increasing. Although the side effects of statins are relatively uncommon, muscle myopathies may develop in response to statin therapy. The invention is the discovery of a correlation between statin related myopathy based on the presence of 3-methylglutaconic acid (3MGA) in the urine. This correlation allows for the screening of both symptomatic and asymptomatic individuals for statin related myopathy.
Claims20
A method of identifying statin related myopathy in an individual comprising:
- collecting a urine sample from the individual undergoing statin therapy;
- and
- analyzing the sample for 3-methylglutaconic acid (3MGA) wherein an elevated level of 3MGA in the sample is correlated with statin related myopathy.
Dependencies are inferred from the claim text.